About Shri Banashankari Pharma Private Limited
Data last updated:
Shri Banashankari Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Nova Sud Pharmaceuticals Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74900KA2014PTC074302. Its GSTIN is 29AAUCS5062P1Z9 (Karnataka).
The company has an authorised share capital of ₹21 Lakh and a paid-up capital of ₹21 Lakh. It is led by directors including Phani Srinivas Ramella and Paidiwar Srinivas.
Its last annual general meeting (AGM) was held on 05 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2022, the company reported a revenue of ₹70,000, a decline of 100% compared to the previous year. For the same year it recorded a net loss of ₹8.6 Lakh and EBITDA of -₹4.9 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 94% over three years and 81% over five years.
The company has 1 deal on record (1 secondary share transfer); the latest was in September 2015.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medplusindia.com.
Company details
Contact details
Shri Banashankari Pharma Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Social Media
- Apps
- Registered AddressM. No: 562/105/1 Portion II 1st Main Road S R Compound South City Road Bannerugh, Atta Road, Bangalore, Karnataka, India – 560076
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Shri Banashankari Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shri Banashankari Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Shri Banashankari Pharma Private Limited
FY 2025 filings availableShri Banashankari Pharma Private Limited reported revenue of ₹70,000 (down 100% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 81% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹70,000 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.6 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shri Banashankari Pharma Private Limited, buy the company report.
Board of directors of Shri Banashankari Pharma Private Limited
Shri Banashankari Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Phani Srinivas Ramella Also directs: Sai Sridhar Pharma Private Limited, Deccan Medisales Private Limited, Venkata Krishna Enterprises Private Limited and 3 more | Director | 24 Sep 2014 | 12 Years 1 Months | Current |
| Paidiwar Srinivas Also directs: Dureleg Manufacturing Private Limited, Sai Sridhar Pharma Private Limited, Wynclark Pharmaceuticals Private Limited and 5 more | Director | 27 Aug 2019 | 7 Years 2 Months | Current |
| Satya Murali Krishna Kammila Also directs: Dureleg Manufacturing Private Limited, Sai Sridhar Pharma Private Limited, Wynclark Pharmaceuticals Private Limited and 5 more | Director | 29 Sep 2021 | 5 Years 1 Months | Current |
Auditor
Shri Banashankari Pharma Private Limited is audited by Gphk & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gphk & Associates | FY 2022 | 008053S |
Shareholding
The shareholding of Shri Banashankari Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shri Banashankari Pharma Private Limited, buy the company report.
Deals & funding
Shri Banashankari Pharma Private Limited has 1 deal on record (1 secondary share transfer); the latest was in September 2015.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2015 | Secondary share transfer | Undisclosed | Buyer: Nova Sud Pharmaceuticals Private Limited , an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Shri Banashankari Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shri Banashankari Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shri Banashankari Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAUCS5062P1Z9 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Shri Banashankari Pharma Private Limited, buy the company report.
Recent activity
Shri Banashankari Pharma Private Limited has 9 board changes on record since 2014: 3 appointments and 6 cessations. The latest: Satya Murali Krishna Kammila was appointed as Director on 29 Sep 2021.
Frequently asked questions
Shri Banashankari Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 March 2014 (12+ years old) and is registered under CIN U74900KA2014PTC074302.
Shri Banashankari Pharma has 3 current directors:
- Phani Srinivas Ramella - Director
- Paidiwar Srinivas - Director
- Satya Murali Krishna Kammila - Director
The latest financial statements of Shri Banashankari Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 05 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shri Banashankari Pharma is 29AAUCS5062P1Z9, registered in Karnataka.
The CIN (Corporate Identification Number) of Shri Banashankari Pharma is U74900KA2014PTC074302. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shri Banashankari Pharma was incorporated on 21 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Bangalore.
Shri Banashankari Pharma has 1 deal on record (1 secondary share transfer); the latest was in September 2015.
Satya Murali Krishna Kammila was appointed as Director on 29 Sep 2021. Paidiwar Srinivas ceased to be Additional Director on 30 Sep 2019. Paidiwar Srinivas was appointed as Director on 27 Aug 2019. Shri Banashankari Pharma has 9 board changes on record in total.
Shri Banashankari Pharma can be reached through the website medplusindia.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Shri Banashankari Pharma is at M. No: 5621051 Portion II 1st Main Road S R Compound South City Road Bannerugh, Atta Road, Bangalore, Karnataka, India – 560076.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
